Cargando…
Treatment of moist desquamation for patients undergoing radiotherapy()()
Moist desquamation occurs in approximately 36% of patients who receive radiation therapy and is associated with severe opioid-resistant pain and discomfort. Moist desquamation is typically at its worst within 1 to 3 weeks after treatment conclusion and resolves over a period of 6 weeks. Herein, we p...
Autores principales: | Suresh, Raagini, Raffi, Jodie, Yuen, Florence, Murase, Jenny E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451763/ https://www.ncbi.nlm.nih.gov/pubmed/30997386 http://dx.doi.org/10.1016/j.ijwd.2018.12.002 |
Ejemplares similares
-
Validation of a Patient-Reported Outcome Measure for Moist Desquamation among Breast Radiotherapy Patients
por: Duzenli, Cheryl, et al.
Publicado: (2022) -
Investigating the role of allergic contact dermatitis in residual ocular surface disease on dupilumab (ROSDD)(,,)()
por: Raffi, Jodie, et al.
Publicado: (2019) -
Nonsteroid management of residual ocular surface disease on dupilumab (ROSDD),()()
por: Raffi, Jodie, et al.
Publicado: (2019) -
Prophylactic Use of Mepitel® Film to Prevent Radiation-Induced Moist Desquamation in Cancer Patients
por: Tayyib, Nahla A
Publicado: (2023) -
Management of grade 3 acute dermatitis with moist desquamation after adjuvant chest wall radiotherapy: a case report
por: Delishaj, Durim, et al.
Publicado: (2020)